Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,354,400 | 1,385,900 | 1,598,200 | 2,006,300 | 1,243,400 |
| Cost of Goods | 262,900 | 285,300 | 385,600 | 542,800 | 250,600 |
| Gross Profit | 1,091,500 | 1,100,600 | 1,212,600 | 1,463,500 | 992,800 |
| Operating Expenses | 741,800 | 731,800 | 825,700 | 948,000 | 627,500 |
| Operating Income | 350,600 | 369,100 | 387,500 | 516,300 | 365,900 |
| Other Income | 52,200 | 17,500 | 21,900 | 20,500 | 21,700 |
| Pre-tax Income | 402,800 | 386,600 | 409,400 | 536,800 | 387,600 |
| Income Tax | 40,700 | 20,200 | 58,400 | 67,000 | 52,700 |
| Net Income Continuous | 362,100 | 366,400 | 351,000 | 469,800 | 334,900 |
| Net Income Discontinuous | 2,707,300 | -1,400 | N/A | N/A | 48,800 |
| Minority Interests | -1,400 | -1,300 | -900 | -200 | -1,200 |
| Net Income | $3,070,800 | $366,300 | $351,900 | $369,900 | $384,900 |
| EPS Basic Total Ops | 5.14 | 0.61 | 0.58 | 0.61 | 0.63 |
| EPS Basic Continuous Ops | 0.61 | 0.61 | 0.58 | 0.78 | 0.55 |
| EPS Basic Discontinuous Ops | 4.53 | 0.00 | N/A | N/A | 0.08 |
| EPS Diluted Total Ops | 5.13 | 0.61 | 0.58 | 0.61 | 0.63 |
| EPS Diluted Continuous Ops | 0.61 | 0.61 | 0.58 | 0.77 | 0.55 |
| EPS Diluted Discontinuous Ops | 4.52 | 0.00 | N/A | N/A | 0.08 |
| EPS Diluted Before Non-Recurring Items | 0.67 | 0.70 | 0.66 | 0.64 | 0.59 |
| EBITDA(a) | $385,100 | $408,700 | $426,000 | $553,000 | $402,800 |